IRCT2015050522112N1已完成未知
Effect of intravitreal autologous plasmin injection, in treatment of diffuse diabetic macular edema
Vice Chancellor for research of Zahedan University of Medical Science0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Diabetic patients suffer from diffuse diabetic macular edema.
- •Exclusion criteria: Uncontrolled hypertension; Unstable blood sugar level; Renal failure; History of Ocular hypertension and, Glaucoma; Ischemic macular or peripheral Retina; History of ocular surgery in last 6 month; Posterior vitreous detachment; Proliferative diabetic retinopathy.
排除标准
- 未提供
研究者
相似试验
Unknown
不适用
Autologous Plasmin and Fibrinolytic System in Diabetic RetinopathyMacular EdemaNCT01478516Hallym University Medical Center40
已完成
3 期
The study for the effect of intravitreous injection of ranibizumab (product name: Lucentis) and subthreshold laser photocoagulation on diabetic macular edemadiabetic macular edemaJPRN-UMIN000017037Jichi Medica University, Saitama Medical Center100
终止
不适用
Evaluation of the Role of Intravitreal Tissue Plasminogen Activator in Treatment of Refractory Diabetic Macular EdemaDiabetic Macular EdemaNCT01141881Mashhad University of Medical Sciences
已完成
2 期
Intravitreal injection of methotrexate in persistent diabetic macular edemaResistant macular edema in diabetic patients.Distrubtion of retinal layers due to edemaIRCT201610098983N2Guilan University of Medical Sciences,Vice chancellor for research42
招募中
1 期
Comparison of the effect of intravitreal injection of bevacizumab (Stevenet) alone with intravitreal injection of bevacizumab and triamcinolone in the treatment of diabetic macular edema with a thickness greater than 500 microns in patientsIRCT20211130053229N1Kerman University of Medical Sciences70